Overview

Semaglutide (Wegovy) Treatment for Trichotillomania

Status:
NOT_YET_RECRUITING
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.
Phase:
PHASE2
Details
Lead Sponsor:
University of Chicago
Treatments:
semaglutide